Shanxi Zhendong Pharmaceutical (300158) — Net Asset Momentum
Shanxi Zhendong Pharmaceutical (300158) recorded a net asset momentum of -28.8% as of December 2024, with net assets of CN¥3.66 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 300158 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Shanxi Zhendong Pharmaceutical Net Asset Momentum (2007–2024)
This chart tracks Shanxi Zhendong Pharmaceutical's year-over-year net asset growth across 18 annual reporting periods from 2007 to 2024. The most recent momentum reading is -28.8%, with net assets of CN¥3.66 Billion CNY as of December 2024. Read Shanxi Zhendong Pharmaceutical debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Shanxi Zhendong Pharmaceutical (2007–2024)
The table below shows the complete annual net asset history for Shanxi Zhendong Pharmaceutical from 2007 to 2024, covering 18 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 300158 market cap.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥3.66 Billion | CN¥4.98 Billion | CN¥1.32 Billion | ▼ -28.8% |
| 2023 | CN¥5.14 Billion | CN¥6.18 Billion | CN¥1.04 Billion | ▼ -1.5% |
| 2022 | CN¥5.22 Billion | CN¥6.55 Billion | CN¥1.33 Billion | ▼ -35.2% |
| 2021 | CN¥8.05 Billion | CN¥10.09 Billion | CN¥2.04 Billion | ▲ +43.0% |
| 2020 | CN¥5.63 Billion | CN¥7.60 Billion | CN¥1.97 Billion | ▲ +3.5% |
| 2019 | CN¥5.44 Billion | CN¥6.92 Billion | CN¥1.47 Billion | ▲ +1.5% |
| 2018 | CN¥5.36 Billion | CN¥7.21 Billion | CN¥1.85 Billion | ▼ -3.5% |
| 2017 | CN¥5.56 Billion | CN¥7.61 Billion | CN¥2.06 Billion | ▲ +5.4% |
| 2016 | CN¥5.27 Billion | CN¥6.87 Billion | CN¥1.60 Billion | ▲ +159.6% |
| 2015 | CN¥2.03 Billion | CN¥4.07 Billion | CN¥2.04 Billion | ▲ +3.1% |
| 2014 | CN¥1.97 Billion | CN¥2.86 Billion | CN¥888.23 Million | ▲ +0.6% |
| 2013 | CN¥1.96 Billion | CN¥2.80 Billion | CN¥838.64 Million | ▲ +3.1% |
| 2012 | CN¥1.90 Billion | CN¥2.58 Billion | CN¥684.26 Million | ▲ +2.2% |
| 2011 | CN¥1.86 Billion | CN¥2.26 Billion | CN¥397.40 Million | ▲ +4.3% |
| 2010 | CN¥1.78 Billion | CN¥2.17 Billion | CN¥389.13 Million | ▲ +395.8% |
| 2009 | CN¥359.31 Million | CN¥643.18 Million | CN¥283.87 Million | ▲ +34.7% |
| 2008 | CN¥266.72 Million | CN¥496.69 Million | CN¥229.98 Million | ▲ +51.2% |
| 2007 | CN¥176.42 Million | CN¥466.70 Million | CN¥290.28 Million | — |